Biofrontera Inc. Ownership Report by Delphi Unternehmensberatung Aktiengesellschaft

The filing discloses the ownership details of Biofrontera Inc. by Delphi Unternehmensberatung Aktiengesellschaft. Delphi Unternehmensberatung Aktiengesellschaft, through its affiliates, holds a significant portion of Biofrontera Inc.'s shares. Specifically, Biofrontera AG, in which Delphi and its affiliates hold approximately 62.2% of the voting stock, directly owns 400,000 common shares. Additionally, Deutsche Balaton Aktiengesellschaft, majority-owned by Delphi, holds 58,884 common shares. The filing also mentions Series D Convertible Preferred Stock, which is convertible into common stock at a price of $0.6249 per share. The reporting period ends on September 16, 2025, and the document is signed by Martin Flick, attorney in fact for Delphi Unternehmensberatung Aktiengesellschaft.